Holdings (Monthly)
Guide ↗
Fidelity MSCI Health Care Index ETF
· Fidelity Covington Trust| # | Name | Ticker | Since | Shares | Shares Δ | Value | Val Δ% | % Port | Cat |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Eli Lilly & Co | 532457108 | Apr 2024 | 382,033 | +11,590 | $438.9M | +26.8% | 13.35% | EC |
| 2 | Johnson & Johnson | 478160104 | Apr 2024 | 1,145,771 | +35,121 | $293.7M | +15.1% | 8.93% | EC |
| 3 | AbbVie Inc | 00287Y109 | Apr 2024 | 841,398 | +26,648 | $211.1M | +22.6% | 6.42% | EC |
| 4 | UnitedHealth Group Inc | 91324P102 | Apr 2024 | 431,779 | +14,196 | $178.9M | +15.7% | 5.44% | EC |
| 5 | Merck & Co Inc | 58933Y105 | Apr 2024 | 1,176,113 | +31,927 | $153.1M | +22.6% | 4.66% | EC |
| 6 | Thermo Fisher Scientific Inc | 883556102 | Apr 2024 | 176,781 | +3,577 | $101.5M | +22.4% | 3.09% | EC |
| 7 | Amgen Inc | 031162100 | Apr 2024 | 256,433 | +8,201 | $98.8M | +14.9% | 3.00% | EC |
| 8 | Abbott Laboratories | 002824100 | Apr 2024 | 828,501 | +26,907 | $87.6M | +20.3% | 2.66% | EC |
| 9 | Gilead Sciences Inc | 375558103 | Apr 2024 | 590,446 | +18,510 | $76.9M | +2.7% | 2.34% | EC |
| 10 | Pfizer Inc | 717081103 | Apr 2024 | 2,705,939 | +84,892 | $67.7M | -3.3% | 2.06% | EC |
| 11 | Bristol-Myers Squibb Co | 110122108 | Apr 2024 | 971,248 | +32,792 | $63.4M | +11.6% | 1.93% | EC |
| 12 | CVS Health Corp | 126650100 | Apr 2024 | 605,189 | +19,989 | $63.2M | +29.7% | 1.92% | EC |
| 13 | Intuitive Surgical Inc | 46120E602 | Apr 2024 | 168,952 | +5,526 | $59.7M | -20.2% | 1.82% | EC |
| 14 | Danaher Corp | 235851102 | Apr 2024 | 302,986 | +9,934 | $59.1M | +12.7% | 1.80% | EC |
| 15 | Vertex Pharmaceuticals Inc | 92532F100 | Apr 2024 | 120,999 | +4,041 | $57.7M | +15.5% | 1.76% | EC |
| 16 | Stryker Corp | 863667101 | Apr 2024 | 163,965 | +5,296 | $53.4M | +6.8% | 1.62% | EC |
| 17 | Medtronic PLC | 000000000 | Apr 2024 | 610,739 | +437,606 | $52.2M | +955.8% | 1.59% | EC |
| 18 | McKesson Corp | 58155Q103 | Apr 2024 | 58,268 | +1,372 | $49.9M | +7.6% | 1.52% | EC |
| 19 | Elevance Health Inc | 036752103 | Apr 2024 | 104,494 | +2,050 | $39.3M | +1.8% | 1.19% | EC |
| 20 | Regeneron Pharmaceuticals Inc | 75886F107 | Apr 2024 | 49,425 | +1,809 | $37.7M | +12.0% | 1.15% | EC |
| 21 | Cigna Group/The | 125523100 | Apr 2024 | 125,422 | +2,278 | $35.0M | -2.2% | 1.06% | EC |
| 22 | Boston Scientific Corp | 101137107 | Apr 2024 | 706,971 | +23,577 | $33.0M | -16.1% | 1.00% | EC |
| 23 | HCA Healthcare Inc | 40412C101 | Apr 2024 | 74,445 | +806 | $30.0M | -6.3% | 0.91% | EC |
| 24 | Cencora Inc | 03073E105 | Apr 2024 | 87,910 | +2,949 | $27.4M | +4.6% | 0.83% | EC |
| 25 | Cardinal Health Inc | 14149Y108 | Apr 2024 | 111,939 | +2,411 | $25.7M | +21.9% | 0.78% | EC |
| 26 | Edwards Lifesciences Corp | 28176E108 | Apr 2024 | 274,258 | +6,744 | $23.6M | +5.7% | 0.72% | EC |
| 27 | Becton Dickinson & Co | 075887109 | Apr 2024 | 135,578 | +4,190 | $22.5M | +14.7% | 0.68% | EC |
| 28 | IDEXX Laboratories Inc | 45168D104 | Apr 2024 | 37,781 | +976 | $21.1M | +2.3% | 0.64% | EC |
| 29 | Humana Inc | 444859102 | Apr 2024 | 57,108 | +1,669 | $20.8M | +58.5% | 0.63% | EC |
| 30 | IQVIA Holdings Inc | 46266C105 | Apr 2024 | 80,727 | +2,218 | $19.0M | +52.6% | 0.58% | EC |
| 31 | Agilent Technologies Inc | 00846U101 | Apr 2024 | 134,433 | +3,745 | $18.6M | +23.2% | 0.57% | EC |
| 32 | Waters Corp | 941848103 | Apr 2024 | 46,780 | +1,445 | $17.7M | +25.9% | 0.54% | EC |
| 33 | Natera Inc | 632307104 | Apr 2024 | 64,051 | +3,470 | $17.2M | +37.3% | 0.52% | EC |
| 34 | Zoetis Inc | 98978V103 | Apr 2024 | 200,057 | -3,090 | $15.5M | -33.8% | 0.47% | EC |
| 35 | Dexcom Inc | 252131107 | Apr 2024 | 183,141 | +3,343 | $15.3M | +42.7% | 0.46% | EC |
| 36 | GE HealthCare Technologies Inc | 36266G107 | Apr 2024 | 217,112 | +7,121 | $14.8M | +15.6% | 0.45% | EC |
| 37 | ResMed Inc | 761152107 | Apr 2024 | 69,318 | +2,029 | $14.6M | +1.7% | 0.44% | EC |
| 38 | Centene Corp | 15135B101 | Apr 2024 | 233,934 | +7,282 | $14.6M | +19.6% | 0.44% | EC |
| 39 | Illumina Inc | 452327109 | Apr 2024 | 70,943 | +630 | $14.6M | +63.3% | 0.44% | EC |
| 40 | Revolution Medicines Inc | 76155X100 | Apr 2024 | 76,953 | +2,412 | $14.4M | +34.3% | 0.44% | EC |
| 41 | Veeva Systems Inc | 922475108 | Apr 2024 | 69,951 | -2,042 | $14.3M | +26.9% | 0.43% | EC |
| 42 | Biogen Inc | 09062X103 | Apr 2024 | 69,831 | +2,209 | $14.2M | +10.7% | 0.43% | EC |
| 43 | Mettler-Toledo International Inc | 592688105 | Apr 2024 | 9,678 | +255 | $13.7M | +13.9% | 0.42% | EC |
| 44 | Alnylam Pharmaceuticals Inc | 02043Q107 | Apr 2024 | 63,090 | +2,189 | $13.0M | -31.2% | 0.39% | EC |
| 45 | Quest Diagnostics Inc | 74834L100 | Apr 2024 | 52,313 | +1,035 | $12.2M | +22.4% | 0.37% | EC |
| 46 | Labcorp Holdings Inc | 504922105 | Jan 2026 | 39,235 | +1,021 | $12.1M | +23.6% | 0.37% | EC |
| 47 | West Pharmaceutical Services Inc | 955306105 | Apr 2024 | 34,263 | +1,078 | $11.7M | +18.3% | 0.36% | EC |
| 48 | Royalty Pharma PLC | 000000000 | Apr 2024 | 195,701 | NEW | $11.4M | — | 0.35% | EC |
| 49 | STERIS PLC | 000000000 | Apr 2024 | 46,559 | NEW | $10.6M | — | 0.32% | EC |
| 50 | Tenet Healthcare Corp | 88033G407 | Apr 2024 | 41,449 | +991 | $10.6M | +47.4% | 0.32% | EC |
| 51 | Insmed Inc | 457669307 | Apr 2024 | 100,200 | +1,887 | $9.9M | -26.3% | 0.30% | EC |
| 52 | Viatris Inc | 92556V106 | Apr 2024 | 554,689 | +23,732 | $9.7M | +22.8% | 0.30% | EC |
| 53 | United Therapeutics Corp | 91307C102 | Apr 2024 | 18,782 | -70 | $9.7M | -9.7% | 0.30% | EC |
| 54 | Incyte Corp | 45337C102 | Apr 2024 | 80,584 | +3,729 | $9.6M | +31.5% | 0.29% | EC |
| 55 | Guardant Health Inc | 40131M109 | Apr 2024 | 57,795 | +5,958 | $9.4M | +107.4% | 0.28% | EC |
| 56 | Moderna Inc | 60770K107 | Apr 2024 | 159,829 | -2,338 | $8.8M | +17.6% | 0.27% | EC |
| 57 | Zimmer Biomet Holdings Inc | 98956P102 | Apr 2024 | 91,889 | +456 | $8.6M | +14.5% | 0.26% | EC |
| 58 | Neurocrine Biosciences Inc | 64125C109 | Apr 2024 | 45,259 | -709 | $7.5M | +24.7% | 0.23% | EC |
| 59 | Roivant Sciences Ltd | 000000000 | Apr 2024 | 221,056 | NEW | $7.5M | — | 0.23% | EC |
| 60 | Medline Inc | 58507V107 | Jul 2026 | 175,373 | NEW | $6.9M | — | 0.21% | EC |
| 61 | Cooper Cos Inc/The | 216648501 | Apr 2024 | 92,713 | +2,375 | $6.7M | +18.0% | 0.20% | EC |
| 62 | Jazz Pharmaceuticals PLC | 000000000 | Apr 2024 | 26,331 | NEW | $6.7M | — | 0.20% | EC |
| 63 | Baxter International Inc | 071813109 | Apr 2024 | 244,882 | +7,045 | $6.4M | +53.2% | 0.19% | EC |
| 64 | Elanco Animal Health Inc | 28414H103 | Apr 2024 | 237,703 | +8,136 | $6.3M | +22.1% | 0.19% | EC |
| 65 | Medpace Holdings Inc | 58506Q109 | Apr 2024 | 10,856 | +492 | $6.3M | +44.4% | 0.19% | EC |
| 66 | Solventum Corp | 83444M101 | Apr 2024 | 70,039 | -2,145 | $6.0M | +23.1% | 0.18% | EC |
| 67 | Revvity Inc | 714046109 | Apr 2024 | 53,129 | +796 | $6.0M | +31.9% | 0.18% | EC |
| 68 | Exelixis Inc | 30161Q104 | Apr 2024 | 111,648 | -5,479 | $5.9M | +13.7% | 0.18% | EC |
| 69 | Penumbra Inc | 70975L107 | Apr 2024 | 17,746 | +594 | $5.7M | +1.8% | 0.17% | EC |
| 70 | Bridgebio Pharma Inc | 10806X102 | Apr 2024 | 69,750 | +3,062 | $5.6M | +17.8% | 0.17% | EC |
| 71 | Align Technology Inc | 016255101 | Apr 2024 | 32,382 | +944 | $5.5M | -1.0% | 0.17% | EC |
| 72 | Charles River Laboratories International Inc | 159864107 | Apr 2024 | 23,486 | +812 | $5.5M | +44.2% | 0.17% | EC |
| 73 | Insulet Corp | 45784P101 | Apr 2024 | 32,909 | +438 | $5.4M | -2.6% | 0.17% | EC |
| 74 | Bio-Techne Corp | 09073M104 | Apr 2024 | 74,551 | +2,714 | $5.4M | +35.2% | 0.16% | EC |
| 75 | Encompass Health Corp | 29261A100 | Apr 2024 | 47,198 | +791 | $5.2M | +13.0% | 0.16% | EC |
| 76 | Corcept Therapeutics Inc | 218352102 | Apr 2024 | 45,653 | +1,685 | $5.2M | +155.5% | 0.16% | EC |
| 77 | BioMarin Pharmaceutical Inc | 09061G101 | Apr 2024 | 84,531 | +449 | $5.1M | +11.9% | 0.15% | EC |
| 78 | State Street Global Advisors | 857492862 | Apr 2024 | 4,904,000 | -1,770,000 | $4.9M | -26.5% | 0.15% | STIV |
| 79 | Molina Healthcare Inc | 60855R100 | Apr 2024 | 24,870 | +1,101 | $4.9M | +5.2% | 0.15% | EC |
| 80 | Ensign Group Inc/The | 29358P101 | Apr 2024 | 27,229 | +467 | $4.9M | -2.9% | 0.15% | EC |
| 81 | Arrowhead Pharmaceuticals Inc | 04280A100 | Apr 2024 | 56,561 | +11 | $4.8M | +15.2% | 0.15% | EC |
| 82 | Halozyme Therapeutics Inc | 40637H109 | Apr 2024 | 56,494 | +2,031 | $4.7M | +34.5% | 0.14% | EC |
| 83 | Glaukos Corp | 377322102 | Apr 2024 | 26,215 | -235 | $4.4M | +15.0% | 0.13% | EC |
| 84 | Avantor Inc | 05352A100 | Apr 2024 | 313,238 | -2,999 | $4.3M | +68.5% | 0.13% | EC |
| 85 | Globus Medical Inc | 379577208 | Apr 2024 | 53,700 | +1,929 | $4.2M | -9.4% | 0.13% | EC |
| 86 | BrightSpring Health Services Inc | 10950A106 | Jan 2026 | 69,119 | +2,466 | $4.1M | +29.1% | 0.13% | EC |
| 87 | Axsome Therapeutics Inc | 05464T104 | Apr 2024 | 18,841 | +2,764 | $4.1M | +23.0% | 0.12% | EC |
| 88 | Universal Health Services Inc | 913903100 | Apr 2024 | 24,277 | -1,206 | $4.1M | -4.6% | 0.12% | EC |
| 89 | Cytokinetics Inc | 23282W605 | Apr 2024 | 52,671 | -1,049 | $4.1M | +18.2% | 0.12% | EC |
| 90 | HealthEquity Inc | 42226A107 | Apr 2024 | 40,141 | +797 | $4.0M | +25.1% | 0.12% | EC |
| 91 | Henry Schein Inc | 806407102 | Apr 2024 | 46,652 | -2,328 | $4.0M | +9.5% | 0.12% | EC |
| 92 | Ionis Pharmaceuticals Inc | 462222100 | Apr 2024 | 74,568 | +3,590 | $3.9M | -27.2% | 0.12% | EC |
| 93 | DaVita Inc | 23918K108 | Apr 2024 | 15,871 | -2,112 | $3.8M | +36.6% | 0.12% | EC |
| 94 | Alkermes PLC | 000000000 | Apr 2024 | 75,274 | NEW | $3.7M | — | 0.11% | EC |
| 95 | TG Therapeutics Inc | 88322Q108 | Apr 2024 | 70,188 | +548 | $3.7M | +55.2% | 0.11% | EC |
| 96 | Crinetics Pharmaceuticals Inc | 22663K107 | Apr 2024 | 43,533 | +2,350 | $3.6M | +127.7% | 0.11% | EC |
| 97 | Repligen Corp | 759916109 | Apr 2024 | 24,792 | +94 | $3.5M | +19.6% | 0.11% | EC |
| 98 | Praxis Precision Medicines Inc | 74006W207 | Jan 2026 | 10,917 | +50 | $3.4M | -3.0% | 0.10% | EC |
| 99 | Krystal Biotech Inc | 501147102 | Apr 2024 | 9,793 | -183 | $3.3M | +27.7% | 0.10% | EC |
| 100 | Protagonist Therapeutics Inc | 74366E102 | Apr 2024 | 24,256 | +1,124 | $3.3M | +44.8% | 0.10% | EC |
| 101 | Madrigal Pharmaceuticals Inc | 558868105 | Apr 2024 | 7,081 | +262 | $3.3M | -6.2% | 0.10% | EC |
| 102 | Chemed Corp | 16359R103 | Apr 2024 | 6,211 | -286 | $3.3M | +19.7% | 0.10% | EC |
| 103 | Bruker Corp | 116794108 | Apr 2024 | 50,946 | +2,115 | $3.2M | +78.6% | 0.10% | EC |
| 104 | Vaxcyte Inc | 92243G108 | Apr 2024 | 58,132 | +3,972 | $3.1M | +1.4% | 0.10% | EC |
| 105 | Lantheus Holdings Inc | 516544103 | Apr 2024 | 30,935 | +507 | $3.1M | +19.7% | 0.09% | EC |
| 106 | Teleflex Inc | 879369106 | Apr 2024 | 21,062 | +600 | $2.9M | +13.6% | 0.09% | EC |
| 107 | Bio-Rad Laboratories Inc | 090572207 | Apr 2024 | 8,592 | +29 | $2.8M | +16.6% | 0.09% | EC |
| 108 | Ligand Pharmaceuticals Inc | 53220K504 | Apr 2024 | 9,216 | +145 | $2.6M | +27.3% | 0.08% | EC |
| 109 | Spyre Therapeutics Inc | 00773J202 | Apr 2024 | 26,643 | +4,226 | $2.6M | +57.0% | 0.08% | EC |
| 110 | Hims & Hers Health Inc | 433000106 | Apr 2024 | 93,866 | +2,688 | $2.6M | +5.2% | 0.08% | EC |
| 111 | Rhythm Pharmaceuticals Inc | 76243J105 | Apr 2024 | 25,957 | -212 | $2.6M | +21.0% | 0.08% | EC |
| 112 | Liquidia Corp | 53635D202 | Apr 2024 | 30,353 | +1,948 | $2.6M | +129.2% | 0.08% | EC |
| 113 | Twist Bioscience Corp | 90184D100 | Apr 2024 | 26,947 | -646 | $2.5M | +53.0% | 0.08% | EC |
| 114 | Apogee Therapeutics Inc | 03770N101 | Apr 2024 | 18,140 | +528 | $2.4M | +66.6% | 0.07% | EC |
| 115 | Xenon Pharmaceuticals Inc | 98420N105 | Apr 2024 | 38,542 | +1,966 | $2.4M | +17.8% | 0.07% | EC |
| 116 | Merit Medical Systems Inc | 589889104 | Apr 2024 | 28,267 | +816 | $2.4M | +28.4% | 0.07% | EC |
| 117 | 10X Genomics Inc | 88025U109 | Apr 2024 | 50,372 | +1,440 | $2.4M | +120.7% | 0.07% | EC |
| 118 | Sotera Health Co | 83601L102 | Apr 2024 | 132,362 | +34,846 | $2.4M | +55.8% | 0.07% | EC |
| 119 | PTC Therapeutics Inc | 69366J200 | Apr 2024 | 33,487 | +72 | $2.3M | +4.8% | 0.07% | EC |
| 120 | Definium Therapeutics Inc | 24477V105 | Jan 2026 | 52,257 | +15,103 | $2.3M | +179.8% | 0.07% | EC |
| 121 | Cogent Biosciences Inc | 19240Q201 | Apr 2024 | 58,328 | +19,977 | $2.3M | +65.4% | 0.07% | EC |
| 122 | Kymera Therapeutics Inc | 501575104 | Apr 2024 | 21,341 | -569 | $2.2M | +24.2% | 0.07% | EC |
| 123 | Travere Therapeutics Inc | 89422G107 | Apr 2024 | 39,446 | +558 | $2.2M | +34.6% | 0.07% | EC |
| 124 | Tempus AI Inc | 88023B103 | Jan 2026 | 49,715 | +6,797 | $2.2M | -8.4% | 0.07% | EC |
| 125 | Envista Holdings Corp | 29415F104 | Apr 2024 | 78,348 | +2,256 | $2.1M | +8.4% | 0.07% | EC |
| 126 | Mirum Pharmaceuticals Inc | 604749101 | Apr 2024 | 20,071 | +2,578 | $2.1M | +24.9% | 0.06% | EC |
| 127 | LivaNova PLC | 000000000 | Apr 2024 | 25,881 | NEW | $2.1M | — | 0.06% | EC |
| 128 | RadNet Inc | 750491102 | Apr 2024 | 31,336 | +912 | $2.0M | +16.2% | 0.06% | EC |
| 129 | Integer Holdings Corp | 45826H109 | Apr 2024 | 16,353 | +331 | $2.0M | +39.8% | 0.06% | EC |
| 130 | Indivior Pharmaceuticals Inc | 45579U109 | Jan 2026 | 49,244 | +565 | $2.0M | +10.0% | 0.06% | EC |
| 131 | CRISPR Therapeutics AG | 000000000 | Apr 2024 | 40,075 | NEW | $1.9M | — | 0.06% | EC |
| 132 | ICU Medical Inc | 44930G107 | Apr 2024 | 11,256 | +554 | $1.9M | +48.7% | 0.06% | EC |
| 133 | Haemonetics Corp | 405024100 | Apr 2024 | 22,085 | +624 | $1.9M | +46.5% | 0.06% | EC |
| 134 | Dianthus Therapeutics Inc | 252828108 | Jan 2026 | 17,465 | +1,418 | $1.9M | +32.5% | 0.06% | EC |
| 135 | IRhythm Holdings Inc | 450056106 | Apr 2024 | 15,537 | +712 | $1.8M | -4.9% | 0.06% | EC |
| 136 | Veracyte Inc | 92337F107 | Apr 2024 | 37,977 | +1,789 | $1.8M | +47.7% | 0.05% | EC |
| 137 | Concentra Group Holdings Parent Inc | 20603L102 | Jan 2026 | 55,009 | +1,584 | $1.7M | +45.0% | 0.05% | EC |
| 138 | Option Care Health Inc | 68404L201 | Apr 2024 | 74,975 | +2,160 | $1.7M | +16.6% | 0.05% | EC |
| 139 | CG oncology Inc | 156944100 | Jan 2026 | 24,074 | +4,369 | $1.7M | +30.3% | 0.05% | EC |
| 140 | Organon & Co | 68622V106 | Apr 2024 | 123,942 | +5,643 | $1.7M | +7.1% | 0.05% | EC |
| 141 | Scholar Rock Holding Corp | 80706P103 | Apr 2024 | 35,479 | +6,511 | $1.7M | +24.3% | 0.05% | EC |
| 142 | Viking Therapeutics Inc | 92686J106 | Apr 2024 | 52,319 | +2,524 | $1.7M | +7.0% | 0.05% | EC |
| 143 | Dyne Therapeutics Inc | 26818M108 | Apr 2024 | 65,771 | +12,055 | $1.7M | +75.7% | 0.05% | EC |
| 144 | Erasca Inc | 29479A108 | Apr 2026 | 85,467 | +7,391 | $1.6M | +86.6% | 0.05% | EC |
| 145 | Brookdale Senior Living Inc | 112463104 | Apr 2024 | 101,695 | -1,644 | $1.5M | +0.1% | 0.05% | EC |
| 146 | Denali Therapeutics Inc | 24823R105 | Apr 2024 | 64,057 | -733 | $1.5M | +21.6% | 0.04% | EC |
| 147 | Oruka Therapeutics Inc | 687604108 | Jan 2026 | 14,937 | +4,978 | $1.4M | +111.6% | 0.04% | EC |
| 148 | Arcutis Biotherapeutics Inc | 03969K108 | Jan 2026 | 53,372 | +2,812 | $1.4M | +22.1% | 0.04% | EC |
| 149 | ACADIA Pharmaceuticals Inc | 004225108 | Apr 2024 | 54,681 | -275 | $1.4M | +14.7% | 0.04% | EC |
| 150 | Amneal Pharmaceuticals Inc | 03168L105 | Apr 2024 | 75,885 | +4,167 | $1.4M | +50.6% | 0.04% | EC |
| 151 | Hinge Health Inc | 433313103 | Jan 2026 | 18,177 | +10,055 | $1.4M | +274.9% | 0.04% | EC |
| 152 | Ideaya Biosciences Inc | 45166A102 | Apr 2024 | 37,935 | +1,080 | $1.3M | +25.6% | 0.04% | EC |
| 153 | National HealthCare Corp | 635906100 | Apr 2024 | 5,907 | -262 | $1.3M | +24.9% | 0.04% | EC |
| 154 | Kiniksa Pharmaceuticals International Plc | 000000000 | Apr 2024 | 17,668 | NEW | $1.3M | — | 0.04% | EC |
| 155 | DENTSPLY SIRONA Inc | 24906P109 | Apr 2024 | 94,546 | +2,712 | $1.3M | +17.1% | 0.04% | EC |
| 156 | Adaptive Biotechnologies Corp | 00650F109 | Apr 2024 | 55,701 | +3,355 | $1.3M | +70.3% | 0.04% | EC |
| 157 | GRAIL Inc | 384747101 | Jan 2026 | 18,033 | +1,937 | $1.2M | +41.0% | 0.04% | EC |
| 158 | Enliven Therapeutics Inc | 29337E102 | Apr 2024 | 22,459 | +7,655 | $1.2M | +101.7% | 0.04% | EC |
| 159 | ImmunityBio Inc | 45256X103 | Apr 2024 | 170,988 | +12,857 | $1.2M | +9.2% | 0.04% | EC |
| 160 | Immunovant Inc | 45258J102 | Apr 2024 | 31,435 | -5,306 | $1.2M | +21.7% | 0.04% | EC |
| 161 | Celldex Therapeutics Inc | 15117B202 | Apr 2024 | 31,885 | +912 | $1.2M | +19.2% | 0.04% | EC |
| 162 | Tango Therapeutics Inc | 87583X109 | Apr 2024 | 44,480 | +24,099 | $1.2M | +174.4% | 0.04% | EC |
| 163 | Doximity Inc | 26622P107 | Apr 2024 | 57,235 | -627 | $1.2M | -15.4% | 0.04% | EC |
| 164 | TransMedics Group Inc | 89377M109 | Apr 2024 | 15,601 | +739 | $1.2M | -20.3% | 0.04% | EC |
| 165 | Neogen Corp | 640491106 | Apr 2024 | 99,033 | +2,856 | $1.2M | +31.9% | 0.04% | EC |
| 166 | Alignment Healthcare Inc | 01625V104 | Apr 2024 | 78,977 | +1,866 | $1.2M | -32.5% | 0.04% | EC |
| 167 | Arcus Biosciences Inc | 03969F109 | Apr 2024 | 41,576 | +1,200 | $1.2M | +13.8% | 0.04% | EC |
| 168 | Waystar Holding Corp | 946784105 | Jan 2026 | 55,172 | +2,688 | $1.2M | +3.8% | 0.04% | EC |
| 169 | Supernus Pharmaceuticals Inc | 868459108 | Apr 2024 | 25,992 | -549 | $1.2M | -8.9% | 0.04% | EC |
| 170 | Prestige Consumer Healthcare Inc | 74112D101 | Apr 2024 | 22,700 | +648 | $1.1M | -8.2% | 0.03% | EC |
| 171 | Vericel Corp | 92346J108 | Apr 2024 | 24,418 | +696 | $1.1M | +36.2% | 0.03% | EC |
| 172 | Acadia Healthcare Co Inc | 00404A109 | Apr 2024 | 37,176 | -2,996 | $1.1M | +5.9% | 0.03% | EC |
| 173 | Privia Health Group Inc | 74276R102 | Apr 2024 | 46,502 | +1,344 | $1.1M | -1.9% | 0.03% | EC |
| 174 | Beam Therapeutics Inc | 07373V105 | Apr 2024 | 42,352 | +186 | $1.1M | -15.5% | 0.03% | EC |
| 175 | Progyny Inc | 74340E103 | Apr 2024 | 34,427 | -2,924 | $1.1M | +54.4% | 0.03% | EC |
| 176 | Relay Therapeutics Inc | 75943R102 | Apr 2024 | 56,058 | -762 | $1.1M | +43.3% | 0.03% | EC |
| 177 | Pediatrix Medical Group Inc | 58502B106 | Apr 2024 | 39,342 | -96 | $1.0M | +17.5% | 0.03% | EC |
| 178 | Nektar Therapeutics | 640268306 | Jan 2026 | 14,592 | +3,461 | $1.0M | +8.9% | 0.03% | EC |
| 179 | Addus HomeCare Corp | 006739106 | Apr 2024 | 8,692 | +240 | $1.0M | +22.6% | 0.03% | EC |
| 180 | Immunome Inc | 45257U108 | Apr 2024 | 43,948 | +969 | $1.0M | +1.5% | 0.03% | EC |
| 181 | Axogen Inc | 05463X106 | Jan 2026 | 23,427 | +1,927 | $989K | +6.5% | 0.03% | EC |
| 182 | Ultragenyx Pharmaceutical Inc | 90400D108 | Apr 2024 | 39,676 | -60 | $988K | +0.7% | 0.03% | EC |
| 183 | LeMaitre Vascular Inc | 525558201 | Apr 2024 | 9,744 | -93 | $987K | -8.6% | 0.03% | EC |
| 184 | uniQure NV | 000000000 | Apr 2024 | 22,287 | NEW | $972K | — | 0.03% | EC |
| 185 | NeoGenomics Inc | 64049M209 | Apr 2024 | 62,331 | +1,800 | $953K | +70.0% | 0.03% | EC |
| 186 | Disc Medicine Inc | 254604101 | Apr 2024 | 11,949 | +787 | $920K | +25.0% | 0.03% | EC |
| 187 | Alumis Inc | 022307102 | Apr 2026 | 32,186 | +2,531 | $909K | +24.2% | 0.03% | EC |
| 188 | CareDx Inc | 14167L103 | Jan 2026 | 20,688 | -3,427 | $904K | +80.2% | 0.03% | EC |
| 189 | LifeStance Health Group Inc | 53228F101 | Apr 2024 | 85,497 | +5,307 | $896K | +47.6% | 0.03% | EC |
| 190 | BioCryst Pharmaceuticals Inc | 09058V103 | Apr 2024 | 99,007 | +2,856 | $889K | +0.9% | 0.03% | EC |
| 191 | ADMA Biologics Inc | 000899104 | Apr 2024 | 104,878 | -4,260 | $887K | -20.7% | 0.03% | EC |
| 192 | Edgewise Therapeutics Inc | 28036F105 | Apr 2024 | 22,934 | -1,210 | $881K | +17.9% | 0.03% | EC |
| 193 | UFP Technologies Inc | 902673102 | Apr 2024 | 3,446 | +96 | $878K | +36.8% | 0.03% | EC |
| 194 | PACS Group Inc | 69380Q107 | Jan 2026 | 18,667 | -3,328 | $859K | +16.4% | 0.03% | EC |
| 195 | AtriCure Inc | 04963C209 | Apr 2024 | 22,662 | -420 | $856K | +31.9% | 0.03% | EC |
| 196 | SELLAS Life Sciences Group Inc | 81642T209 | Jul 2026 | 85,332 | NEW | $854K | — | 0.03% | EC |
| 197 | Tarsus Pharmaceuticals Inc | 87650L103 | Apr 2024 | 14,156 | -708 | $836K | -11.6% | 0.03% | EC |
| 198 | Trevi Therapeutics Inc | 89532M101 | Jan 2026 | 45,551 | +5,074 | $831K | +49.3% | 0.03% | EC |
| 199 | Fortrea Holdings Inc | 34965K107 | Apr 2024 | 43,277 | +1,694 | $830K | +73.5% | 0.03% | EC |
| 200 | Clover Health Investments Corp | 18914F103 | Apr 2024 | 193,636 | +2,535 | $807K | +53.6% | 0.02% | EC |
| 201 | Agios Pharmaceuticals Inc | 00847X104 | Apr 2024 | 26,897 | +1,666 | $807K | +14.3% | 0.02% | EC |
| 202 | Establishment Labs Holdings Inc | 000000000 | Apr 2024 | 8,704 | NEW | $805K | — | 0.02% | EC |
| 203 | AtaiBeckley Inc | 04650F101 | Jan 2026 | 112,181 | +36,470 | $805K | +155.7% | 0.02% | EC |
| 204 | CorVel Corp | 221006109 | Apr 2024 | 13,368 | -724 | $803K | -0.8% | 0.02% | EC |
| 205 | Harmony Biosciences Holdings Inc | 413197104 | Apr 2024 | 22,673 | +3,162 | $799K | +31.0% | 0.02% | EC |
| 206 | Newamsterdam Pharma Co NV | 000000000 | Apr 2024 | 28,680 | NEW | $797K | — | 0.02% | EC |
| 207 | Biohaven Ltd | 000000000 | Apr 2024 | 58,971 | NEW | $796K | — | 0.02% | EC |
| 208 | Enovis Corp | 194014502 | Apr 2024 | 26,989 | +768 | $787K | +28.0% | 0.02% | EC |
| 209 | VeraDermics Inc | 922967104 | Jul 2026 | 7,340 | NEW | $771K | — | 0.02% | EC |
| 210 | Syndax Pharmaceuticals Inc | 87164F105 | Apr 2024 | 40,330 | +2,847 | $768K | -4.4% | 0.02% | EC |
| 211 | Astrana Health Inc | 03763A207 | Apr 2024 | 21,507 | +624 | $765K | +7.3% | 0.02% | EC |
| 212 | Aurinia Pharmaceuticals Inc | 05156V102 | Apr 2024 | 50,551 | -1,474 | $752K | -6.0% | 0.02% | EC |
| 213 | Omnicell Inc | 68213N109 | Apr 2024 | 21,068 | -87 | $745K | -15.0% | 0.02% | EC |
| 214 | Nuvation Bio Inc | 67080N101 | Jan 2026 | 115,286 | +13,676 | $730K | +61.4% | 0.02% | EC |
| 215 | Novocure Ltd | 000000000 | Apr 2024 | 48,663 | NEW | $722K | — | 0.02% | EC |
| 216 | UroGen Pharma Ltd | 000000000 | Apr 2024 | 18,561 | NEW | $710K | — | 0.02% | EC |
| 217 | Innoviva Inc | 45781M101 | Apr 2024 | 33,538 | +960 | $703K | -6.1% | 0.02% | EC |
| 218 | ANI Pharmaceuticals Inc | 00182C103 | Apr 2024 | 8,812 | +624 | $698K | +7.3% | 0.02% | EC |
| 219 | Sarepta Therapeutics Inc | 803607100 | Apr 2024 | 46,891 | +1,344 | $697K | -26.7% | 0.02% | EC |
| 220 | Viridian Therapeutics Inc | 92790C104 | Apr 2024 | 36,733 | +6,605 | $695K | +71.1% | 0.02% | EC |
| 221 | Amylyx Pharmaceuticals Inc | 03237H101 | Apr 2024 | 34,142 | +3,924 | $693K | +43.4% | 0.02% | EC |
| 222 | Perrigo Co PLC | 000000000 | Apr 2024 | 67,763 | NEW | $685K | — | 0.02% | EC |
| 223 | MBX Biosciences Inc | 55287L101 | Apr 2026 | 10,380 | +75 | $684K | +119.8% | 0.02% | EC |
| 224 | Nurix Therapeutics Inc | 67080M103 | Jan 2026 | 29,479 | -5,110 | $684K | +18.4% | 0.02% | EC |
| 225 | CONMED Corp | 207410101 | Apr 2024 | 14,669 | +300 | $679K | +28.9% | 0.02% | EC |
| 226 | Iovance Biotherapeutics Inc | 462260100 | Apr 2024 | 166,388 | +25,465 | $677K | +43.0% | 0.02% | EC |
| 227 | Palvella Therapeutics Inc | 697947109 | Jan 2026 | 4,864 | +368 | $676K | +17.2% | 0.02% | EC |
| 228 | Mineralys Therapeutics Inc | 603170101 | Jan 2026 | 26,449 | +5,471 | $675K | +20.7% | 0.02% | EC |
| 229 | Recursion Pharmaceuticals Inc | 75629V104 | Apr 2024 | 223,214 | +19,963 | $670K | -4.8% | 0.02% | EC |
| 230 | Vera Therapeutics Inc | 92337R101 | Apr 2024 | 20,341 | +2,778 | $653K | +4.4% | 0.02% | EC |
| 231 | Intellia Therapeutics Inc | 45826J105 | Apr 2024 | 61,000 | +10,293 | $651K | -4.7% | 0.02% | EC |
| 232 | Xeris Biopharma Holdings Inc | 98422E103 | Jan 2026 | 80,356 | +2,304 | $649K | +35.8% | 0.02% | EC |
| 233 | Celcuity Inc | 15102K100 | Jan 2026 | 7,465 | -2,091 | $645K | -44.4% | 0.02% | EC |
| 234 | Pennant Group Inc/The | 70805E109 | Apr 2024 | 15,779 | -557 | $636K | +24.3% | 0.02% | EC |
| 235 | Tandem Diabetes Care Inc | 875372203 | Apr 2024 | 32,447 | +936 | $633K | +2.8% | 0.02% | EC |
| 236 | AMN Healthcare Services Inc | 001744101 | Apr 2024 | 18,596 | +1,459 | $625K | +78.3% | 0.02% | EC |
| 237 | Inspire Medical Systems Inc | 457730109 | Apr 2024 | 12,317 | -546 | $618K | -14.4% | 0.02% | EC |
| 238 | GeneDx Holdings Corp | 81663L200 | Jan 2026 | 9,458 | +264 | $616K | +6.5% | 0.02% | EC |
| 239 | Kodiak Sciences Inc | 50015M109 | Apr 2026 | 14,697 | +1,380 | $611K | +5.5% | 0.02% | EC |
| 240 | BioLife Solutions Inc | 09062W204 | Apr 2024 | 19,204 | +552 | $601K | +52.8% | 0.02% | EC |
| 241 | Butterfly Network Inc | 124155102 | Apr 2026 | 84,042 | -8,980 | $598K | +34.1% | 0.02% | EC |
| 242 | US Physical Therapy Inc | 90337L108 | Apr 2024 | 7,541 | +684 | $596K | +22.1% | 0.02% | EC |
| 243 | Surgery Partners Inc | 86881A100 | Apr 2024 | 38,240 | +3,195 | $589K | +19.8% | 0.02% | EC |
| 244 | Harrow Inc | 415858109 | Apr 2024 | 15,109 | +432 | $586K | -1.5% | 0.02% | EC |
| 245 | Ocular Therapeutix Inc | 67576A100 | Jan 2026 | 71,456 | -1,263 | $584K | -14.3% | 0.02% | EC |
| 246 | Precigen Inc | 74017N105 | Jan 2026 | 92,500 | +11,396 | $580K | +71.9% | 0.02% | EC |
| 247 | Guardian Pharmacy Services Inc | 40145W101 | Jan 2026 | 14,451 | +3,203 | $571K | +36.9% | 0.02% | EC |
| 248 | Teladoc Health Inc | 87918A105 | Apr 2024 | 83,458 | +2,400 | $560K | +14.0% | 0.02% | EC |
| 249 | Artivion Inc | 228903100 | Apr 2024 | 20,435 | +2,043 | $548K | -16.8% | 0.02% | EC |
| 250 | QuidelOrtho Corp | 219798105 | Apr 2024 | 32,585 | +936 | $546K | +40.4% | 0.02% | EC |
| 251 | MannKind Corp | 56400P706 | Apr 2024 | 139,696 | +4,008 | $546K | +42.2% | 0.02% | EC |
| 252 | Azenta Inc | 114340102 | Apr 2024 | 19,310 | +552 | $543K | +17.9% | 0.02% | EC |
| 253 | Integra LifeSciences Holdings Corp | 457985208 | Apr 2024 | 32,504 | +2,602 | $541K | +71.7% | 0.02% | EC |
| 254 | Ardelyx Inc | 039697107 | Apr 2024 | 108,980 | -2,106 | $539K | -23.3% | 0.02% | EC |
| 255 | Rapport Therapeutics Inc | 75383L102 | Jan 2026 | 13,063 | -583 | $535K | +18.4% | 0.02% | EC |
| 256 | Collegium Pharmaceutical Inc | 19459J104 | Apr 2024 | 15,115 | +432 | $535K | +8.0% | 0.02% | EC |
| 257 | Alphatec Holdings Inc | 02081G201 | Apr 2024 | 55,741 | +1,608 | $531K | +0.4% | 0.02% | EC |
| 258 | Taysha Gene Therapies Inc | 877619106 | Jan 2026 | 87,466 | +24,981 | $513K | +28.4% | 0.02% | EC |
| 259 | First Tracks Biotherapeutics Inc | 337185102 | Apr 2026 | 11,560 | +5,142 | $509K | +240.9% | 0.02% | EC |
| 260 | Stoke Therapeutics Inc | 86150R107 | Jan 2026 | 17,567 | -845 | $507K | -15.8% | 0.02% | EC |
| 261 | Damora Therapeutics Inc | 000000000 | Apr 2024 | 17,196 | NEW | $499K | — | 0.02% | EC |
| 262 | Procept Biorobotics Corp | 74276L105 | Apr 2024 | 26,106 | +744 | $486K | -20.3% | 0.01% | EC |
| 263 | Vir Biotechnology Inc | 92764N102 | Apr 2024 | 55,806 | +1,608 | $483K | -12.7% | 0.01% | EC |
| 264 | Novavax Inc | 670002401 | Apr 2024 | 64,499 | +1,848 | $472K | -4.9% | 0.01% | EC |
| 265 | Pacira BioSciences Inc | 695127100 | Apr 2024 | 17,794 | -1,667 | $470K | -5.3% | 0.01% | EC |
| 266 | Certara Inc | 15687V109 | Apr 2024 | 57,482 | +1,656 | $466K | +36.1% | 0.01% | EC |
| 267 | Schrodinger Inc/United States | 80810D103 | Apr 2024 | 30,589 | +888 | $463K | +30.4% | 0.01% | EC |
| 268 | HeartFlow Inc | 42238D107 | Jan 2026 | 18,338 | +8,775 | $463K | +62.6% | 0.01% | EC |
| 269 | AdaptHealth Corp | 00653Q102 | Apr 2024 | 40,362 | -2,943 | $436K | -23.2% | 0.01% | EC |
| 270 | EyePoint Inc | 30233G209 | Apr 2026 | 35,128 | +954 | $430K | -4.6% | 0.01% | EC |
| 271 | Xencor Inc | 98401F105 | Apr 2024 | 21,086 | -1,837 | $426K | +55.8% | 0.01% | EC |
| 272 | Personalis Inc | 71535D106 | Apr 2026 | 32,319 | +7,881 | $409K | +203.3% | 0.01% | EC |
| 273 | AnaptysBio Inc | 032724106 | Apr 2024 | 7,513 | +1,095 | $401K | -5.0% | 0.01% | EC |
| 274 | Zymeworks Inc | 98985Y108 | Apr 2024 | 18,267 | +1,473 | $401K | -13.3% | 0.01% | EC |
| 275 | Corvus Pharmaceuticals Inc | 221015100 | Jul 2026 | 29,935 | NEW | $397K | — | 0.01% | EC |
| 276 | Zenas Biopharma Inc | 98937L105 | Jan 2026 | 12,595 | +5,256 | $396K | +179.3% | 0.01% | EC |
| 277 | Jade Biosciences Inc | 008064206 | Jul 2026 | 19,767 | NEW | $390K | — | 0.01% | EC |
| 278 | Bicara Therapeutics Inc | 055477103 | Jan 2026 | 14,345 | +1,585 | $389K | +41.2% | 0.01% | EC |
| 279 | Omeros Corp | 682143102 | Jul 2026 | 32,501 | NEW | $385K | — | 0.01% | EC |
| 280 | MoonLake Immunotherapeutics | 61559X104 | Apr 2024 | 20,634 | +6,066 | $380K | +59.5% | 0.01% | EC |
| 281 | SI-BONE Inc | 825704109 | Apr 2024 | 21,235 | +2,417 | $377K | +61.8% | 0.01% | EC |
| 282 | Monte Rosa Therapeutics Inc | 61225M102 | Apr 2026 | 22,810 | +8,656 | $377K | +39.0% | 0.01% | EC |
| 283 | iRadimed Corp | 46266A109 | Apr 2024 | 3,971 | +120 | $361K | +12.3% | 0.01% | EC |
| 284 | Castle Biosciences Inc | 14843C105 | Apr 2024 | 12,441 | -1,090 | $348K | +5.1% | 0.01% | EC |
| 285 | Phibro Animal Health Corp | 71742Q106 | Apr 2024 | 9,556 | +264 | $347K | -29.7% | 0.01% | EC |
| 286 | ArriVent Biopharma Inc | 04272N102 | Jan 2026 | 11,553 | +1,685 | $345K | +12.3% | 0.01% | EC |
| 287 | STAAR Surgical Co | 852312305 | Apr 2024 | 14,117 | -574 | $344K | -11.2% | 0.01% | EC |
| 288 | Nutex Health Inc | 67079U306 | Jan 2026 | 2,320 | +620 | $342K | +68.8% | 0.01% | EC |
| 289 | WaVe Life Sciences Ltd | 000000000 | Apr 2024 | 61,697 | NEW | $340K | — | 0.01% | EC |
| 290 | Aveanna Healthcare Holdings Inc | 05356F105 | Jan 2026 | 36,172 | +12,221 | $340K | +116.8% | 0.01% | EC |
| 291 | Tyra Biosciences Inc | 90240B106 | Apr 2026 | 10,602 | +4,480 | $338K | +58.9% | 0.01% | EC |
| 292 | Kura Oncology Inc | 50127T109 | Apr 2024 | 35,429 | +1,008 | $319K | +5.0% | 0.01% | EC |
| 293 | HealthStream Inc | 42222N103 | Apr 2024 | 11,375 | +336 | $319K | +39.2% | 0.01% | EC |
| 294 | MeiraGTx Holdings plc | 000000000 | Apr 2024 | 26,392 | NEW | $311K | — | 0.01% | EC |
| 295 | Geron Corp | 374163103 | Apr 2024 | 237,415 | +6,816 | $306K | -13.8% | 0.01% | EC |
| 296 | Amphastar Pharmaceuticals Inc | 03209R103 | Apr 2024 | 15,339 | -2,221 | $306K | -20.7% | 0.01% | EC |
| 297 | Sionna Therapeutics Inc | 829401108 | Jul 2026 | 6,417 | NEW | $302K | — | 0.01% | EC |
| 298 | Theravance Biopharma Inc | 000000000 | Apr 2024 | 17,926 | NEW | $302K | — | 0.01% | EC |
| 299 | Maze Therapeutics Inc | 578784100 | Jul 2026 | 11,155 | NEW | $300K | — | 0.01% | EC |
| 300 | Cullinan Therapeutics Inc | 230031106 | Apr 2024 | 17,979 | +3,195 | $297K | +53.8% | 0.01% | EC |
| 301 | Arbutus Biopharma Corp | 03879J100 | Jan 2026 | 66,333 | +1,896 | $288K | +6.4% | 0.01% | EC |
| 302 | LB Pharmaceuticals Inc | 50180M108 | Jul 2026 | 7,157 | NEW | $287K | — | 0.01% | EC |
| 303 | Annexon Inc | 03589W102 | Apr 2026 | 56,295 | +1,608 | $287K | -10.7% | 0.01% | EC |
| 304 | Olema Pharmaceuticals Inc | 68062P106 | Apr 2026 | 24,851 | +7,543 | $285K | +14.1% | 0.01% | EC |
| 305 | Pulse Biosciences Inc | 74587B101 | Jan 2026 | 8,079 | -1,166 | $284K | +45.0% | 0.01% | EC |
| 306 | Inhibrx Biosciences Inc | 45720N103 | Apr 2026 | 3,429 | +96 | $281K | -34.7% | 0.01% | EC |
| 307 | Janux Therapeutics Inc | 47103J105 | Apr 2024 | 18,188 | +528 | $276K | +8.7% | 0.01% | EC |
| 308 | Tilray Brands Inc | 88688T209 | Jan 2026 | 57,332 | +1,656 | $260K | -25.1% | 0.01% | EC |
| 309 | Kestra Medical Technologies Ltd | 000000000 | Apr 2024 | 11,314 | NEW | $258K | — | 0.01% | EC |
| 310 | Sana Biotechnology Inc | 799566104 | Apr 2024 | 80,330 | +2,304 | $251K | -2.1% | 0.01% | EC |
| 311 | Savara Inc | 805111101 | Apr 2026 | 43,814 | +12,104 | $239K | +44.0% | 0.01% | EC |
| 312 | OPKO Health Inc | 68375N103 | Apr 2024 | 180,345 | -19,757 | $238K | +5.7% | 0.01% | EC |
| 313 | CytomX Therapeutics Inc | 23284F105 | Apr 2026 | 76,464 | +2,208 | $237K | -24.4% | 0.01% | EC |
| 314 | CorMedix Inc | 21900C308 | Jan 2026 | 31,479 | -2,525 | $237K | -8.2% | 0.01% | EC |
| 315 | Phreesia Inc | 71944F106 | Apr 2024 | 21,655 | -5,663 | $232K | -7.6% | 0.01% | EC |
| 316 | ORIC Pharmaceuticals Inc | 68622P109 | Jan 2026 | 20,639 | +600 | $228K | +15.4% | 0.01% | EC |
| 317 | Arvinas Inc | 04335A105 | Apr 2024 | 25,787 | +744 | $207K | -16.5% | 0.01% | EC |
| 318 | Phathom Pharmaceuticals Inc | 71722W107 | Apr 2024 | 22,619 | +648 | $198K | -19.6% | 0.01% | EC |
| 319 | Septerna Inc | 81734D104 | Apr 2026 | 4,401 | -726 | $152K | +24.5% | 0.00% | EC |
| 320 | Prime Medicine Inc | 74168J101 | Jan 2026 | 49,767 | +10,240 | $145K | +3.7% | 0.00% | EC |
| 321 | Ginkgo Bioworks Holdings Inc | 37611X209 | Jan 2026 | 17,486 | +504 | $141K | -1.5% | 0.00% | EC |
| 322 | GoodRx Holdings Inc | 38246G108 | Apr 2024 | 43,092 | +1,248 | $132K | +34.0% | 0.00% | EC |
| 323 | ARS Pharmaceuticals Inc | 82835W108 | Apr 2024 | 22,392 | -2,525 | $115K | -44.2% | 0.00% | EC |
| 324 | Embecta Corp | 29082K105 | Apr 2024 | 26,256 | +744 | $96K | -59.1% | 0.00% | EC |
| 325 | Chicago Mercantile Exchange | 000000000 | Apr 2024 | 53 | NEW | $92K | — | 0.00% | DE |
| 326 | Capricor Therapeutics Inc | 14070B309 | Apr 2026 | 21,985 | -480 | $85K | -88.8% | 0.00% | EC |
| 327 | Upstream Bio Inc | 91678A107 | Jan 2026 | 11,496 | +336 | $73K | -29.2% | 0.00% | EC |
| 328 | Compass Therapeutics Inc | 20454B104 | Apr 2026 | 37,125 | -14,028 | $71K | -21.7% | 0.00% | EC |
| 329 | Evommune Inc | 30054Y107 | Jul 2026 | 5,133 | NEW | $58K | — | 0.00% | EC |
| 330 | CONTRA AKOUOS INC | 009CVR036 | Apr 2024 | 11,863 | — | $2K | -21.1% | 0.00% | EC |
| 331 | OMNIAB INC | 68218J202 | Apr 2024 | 3,335 | — | $1K | -19.1% | 0.00% | EC |
| 332 | CONTRA HOLOGIC INCORPO | 436CVR021 | Apr 2026 | 100,790 | — | $1K | +0.0% | 0.00% | EC |
| 333 | OMNIAB INC | 68218J301 | Apr 2024 | 3,335 | — | $867 | -27.8% | 0.00% | EC |
| 334 | CONTRA CHINOOK THERAPE | 169CVR016 | Apr 2024 | 24,218 | — | $0 | +0.0% | 0.00% | EC |
| 335 | CONTRA AKERO THERAPEUT | 009CVR044 | Jan 2026 | 22,341 | — | $0 | +0.0% | 0.00% | EC |
| 336 | CONTRA ARCELLX INC | 039CVR014 | Apr 2026 | 12,690 | — | $0 | -100.0% | 0.00% | EC |
| 337 | Chicago Mercantile Exchange | 000000000 | Apr 2024 | 6 | NEW | $-9774 | — | -0.00% | DE |
| ✕ | Masimo Corp | 574795100 | — | 21,108 | SOLD | $3.8M | — | — | — |
| ✕ | Nuvalent Inc | 670703107 | — | 18,465 | SOLD | $1.9M | — | — | — |
| ✕ | Catalyst Pharmaceuticals Inc | 14888U101 | — | 54,185 | SOLD | $1.5M | — | — | — |
| ✕ | Apellis Pharmaceuticals Inc | 03753U106 | — | 35,150 | SOLD | $1.4M | — | — | — |
| ✕ | Terns Pharmaceuticals Inc | 880881107 | — | 26,088 | SOLD | $1.4M | — | — | — |
| ✕ | Soleno Therapeutics Inc | 834203309 | — | 21,263 | SOLD | $1.1M | — | — | — |
| ✕ | Select Medical Holdings Corp | 81619Q105 | — | 51,090 | SOLD | $0.8M | — | — | — |
| ✕ | Avanos Medical Inc | 05350V106 | — | 20,939 | SOLD | $0.5M | — | — | — |
| ✕ | KalVista Pharmaceuticals Inc | 483497103 | — | 13,259 | SOLD | $0.4M | — | — | — |
| ✕ | Myriad Genetics Inc | 62855J104 | — | 41,272 | SOLD | $0.2M | — | — | — |
| ✕ | MiMedx Group Inc | 602496101 | — | 52,532 | SOLD | $0.2M | — | — | — |
| ✕ | Fulgent Genetics Inc | 359664109 | — | 8,753 | SOLD | $0.1M | — | — | — |
| ✕ | Ardent Health Inc | 03980N107 | — | 13,112 | SOLD | $0.1M | — | — | — |
| ✕ | Standard BioTools Inc | 34385P108 | — | 118,488 | SOLD | $0.1M | — | — | — |
| ✕ | LENZ Therapeutics Inc | 52635N103 | — | 5,375 | SOLD | $0.0M | — | — | — |